Animal imaging testing is a cornerstone of modern preclinical research, enabling non-invasive and longitudinal evaluation of anatomical structures, physiological functions, and disease progression in laboratory animals. By applying advanced modalities such as micro-CT, MRI, PET/SPECT, ultrasound, and optical imaging, accredited third-party laboratories generate critical quantitative data that support medical device development, pharmaceutical research, and regulatory submissions. This article provides a comprehensive overview of animal imaging test samples, testing items, methods, and practical applications.
Technical Overview
Animal imaging testing refers to the application of clinical and dedicated preclinical imaging technologies to laboratory animals in order to visualize, characterize, and quantify anatomical, functional, physiological, and molecular information in vivo. As a non-destructive and frequently non-invasive evaluation approach, imaging enables longitudinal study designs in which the same animal can be monitored at multiple time points, significantly reducing animal numbers and inter-individual variability while improving statistical power and translational relevance.
Animal imaging trials are typically conducted in accredited third-party laboratories or research institutions operating under quality management systems compliant with ISO 13485 or the OECD Principles of Good Laboratory Practice (GLP). Animal welfare is governed by ISO 10993-2 (Biological evaluation of medical devices — Part 2: Animal welfare requirements) and the corresponding GB/T 16886 series, while study reporting commonly follows the ARRIVE guidelines to ensure transparency, completeness, and reproducibility.
- Non-invasive or minimally invasive visualization of internal structures
- Longitudinal monitoring of the same subject across multiple time points
- Quantitative, reproducible, and statistically robust data generation
- Direct support for regulatory submissions and translational research
Testing Samples
The selection of an appropriate animal model is a critical determinant of imaging test design. Species are chosen based on anatomical similarity to humans, size compatibility with imaging equipment, disease relevance, and ethical and regulatory considerations.
Rodents (Mice and Rats)
Rodents are the most widely used animals in imaging research due to their small size, well-characterized genetics, and compatibility with high-resolution preclinical scanners. Mice and rats are routinely imaged using micro-CT, high-field small-animal MRI, micro-PET/SPECT, and optical imaging platforms for oncology, neurology, musculoskeletal, and metabolic studies.
Rabbits
Rabbits provide an intermediate body size that accommodates both clinical and preclinical imaging systems. They are commonly used in atherosclerosis models, vascular injury studies, osteomyelitis research, and orthopedic evaluations, and are well suited to digital radiography, CT angiography, and ultrasound assessment.
Canines (Beagles)
Beagles are favored for cardiovascular, pharmacology, and long-term implant studies because of their manageable temperament and physiological similarity to humans in heart size and coronary anatomy. Imaging protocols typically employ clinical CT, MRI, DSA, and echocardiography.
Swine (Minipigs and Domestic Pigs)
Pigs are an excellent large-animal model owing to their anatomical and physiological resemblance to humans, particularly in the cardiovascular, dermal, renal, and skeletal systems. They are extensively used in the preclinical evaluation of stents, heart valves, vascular grafts, orthopedic devices, and dental implants under ISO 10993-6 and device-specific standards such as ISO 7198 for cardiovascular implants.
Non-Human Primates
Non-human primates offer the highest translational relevance for neurological, cognitive, and infectious disease research. Imaging studies involving primates are subject to the strictest ethical review and are performed only when scientifically justified, typically using clinical-grade PET/MRI and CT platforms.
Implanted Medical Devices and Biomaterials
Animals bearing implanted devices, such as vascular stents, orthopedic fixation plates, spinal cages, artificial joints, occluders, and absorbable scaffolds, constitute a distinct category of test subjects. Imaging is used to verify placement, detect migration or fracture, monitor tissue integration, and track in vivo degradation over scheduled follow-up periods.
Testing Items
Animal imaging test items span morphological, functional, and molecular endpoints. Representative items include:
- Anatomical and morphological imaging of organs, soft tissue, and skeletal structures
- Bone microarchitecture, bone mineral density, and fracture healing assessment
- Cardiac structure and function evaluation, including ejection fraction, wall motion, and chamber dimensions
- Vascular morphology, patency, stenosis grading, and hemodynamic analysis
- Tumor volume measurement, growth kinetics, and metastasis monitoring
- Dynamic contrast-enhanced studies of perfusion and vascular permeability
- Metabolic and molecular imaging of receptor expression, inflammation, and gene expression
- Implant position, alignment, migration, wear, and structural integrity verification
- In vivo degradation tracking of absorbable implants and tissue-engineered scaffolds
- Brain structure and neurofunctional imaging in neuroscience models
- Pulmonary, hepatic, and renal functional imaging
- Fat quantification and whole-body composition analysis
Testing Methods
Micro-CT (Micro Computed Tomography)
Micro-CT provides micron-scale three-dimensional visualization of bone, lung, vascular casts, and ex vivo or in vivo specimens. It is the method of choice for trabecular microarchitecture, cortical thickness, bone mineral density, and bone regeneration studies, delivering isotropic spatial resolution down to a few micrometers.
Magnetic Resonance Imaging (MRI)
High-field small-animal MRI offers excellent soft-tissue contrast without ionizing radiation. Applications include neuroimaging, cardiac MRI, tumor characterization, diffusion and perfusion imaging, and MR angiography. MRI safety and compatibility of implanted devices are assessed in accordance with ASTM F2503 labeling practice.
PET/CT and SPECT/CT
Nuclear imaging modalities use radiolabeled tracers such as 18F-FDG to quantify glucose metabolism, receptor binding, and target engagement with very high sensitivity. Combined PET/CT or SPECT/CT systems co-register functional and anatomical data, enabling precise localization of molecular signals in oncology, cardiology, and neurology studies.
Ultrasound and Doppler Imaging
High-frequency ultrasound provides real-time assessment of cardiac function, blood flow velocity, vascular diameter, and organ morphology. Doppler modes quantify hemodynamic parameters such as peak systolic velocity and resistive index, supporting cardiovascular device evaluation and pharmacology studies.
Optical Imaging (Bioluminescence and Fluorescence)
Optical imaging detects luciferase-expressing cells or fluorescent probes with high throughput and sensitivity. It is widely applied in tumor burden monitoring, infectious disease tracking, cell therapy biodistribution, and longitudinal treatment response studies.
Digital Radiography (DR) and Digital Subtraction Angiography (DSA)
Digital radiography delivers rapid two-dimensional skeletal and thoracic surveys, while DSA visualizes the vascular system following contrast injection. DSA is essential for evaluating vascular devices such as stents, filters, occluders, and embolization products, providing immediate confirmation of device deployment and vessel patency.
Image Post-Processing and Quantitative Analysis
Acquired images are processed using standardized software workflows for three-dimensional reconstruction, segmentation, volume measurement, density calibration, and statistical mapping. Quantitative outputs are documented in accordance with approved study protocols, ensuring traceability, integrity, and reproducibility of results.
Applications
Animal imaging trials serve a broad spectrum of research, development, and regulatory purposes:
- Preclinical safety and performance evaluation of medical devices prior to clinical trials
- Pharmacodynamic, pharmacokinetic, and biodistribution studies in drug development
- Validation of tumor, cardiovascular, neurological, and metabolic disease models
- Assessment of tissue-engineered products, biomaterials, and regenerative therapies
- Long-term follow-up of implant integration, degradation, and biocompatibility under the ISO 10993 framework
- Generation of supporting evidence for regulatory dossiers submitted to national medical device and pharmaceutical authorities
- Basic research into disease mechanisms, progression, and therapeutic intervention
FAQ
What is animal imaging testing?
Animal imaging testing is the application of imaging technologies such as CT, MRI, PET, SPECT, ultrasound, and optical imaging to laboratory animals in order to obtain in vivo anatomical, functional, or molecular data for research, product development, or regulatory evaluation purposes.
Why is imaging preferred over terminal histology in animal studies?
Imaging allows the same animal to be examined repeatedly over time, reducing the number of animals required, lowering inter-individual variability, and enabling true longitudinal tracking of disease progression or device performance. Histology remains a complementary confirmatory endpoint at scheduled sacrifice.
Which animal welfare standards apply?
Studies must comply with ISO 10993-2 and GB/T 16886-2 for animal welfare requirements, applicable national laboratory animal regulations, and institutional animal care and use committee (IACUC) or equivalent ethical approval. The 3R principles of replacement, reduction, and refinement guide all study design decisions.
Can clinical scanners be used for small animals?
Larger species such as pigs, dogs, and non-human primates can often be imaged on clinical systems. Rodents generally require dedicated high-resolution preclinical scanners such as micro-CT, micro-PET/SPECT, and high-frequency ultrasound to achieve adequate spatial resolution.
How long does a typical animal imaging study take?
Duration depends on the study objective. A single imaging session may take from thirty minutes to several hours including anesthesia, whereas longitudinal studies with scheduled follow-ups may span weeks to months, and long-term implant evaluations may extend beyond one or two years.
Are animal imaging data accepted for regulatory submissions?
Yes. Imaging data generated under GLP-compliant or ISO 13485-certified quality systems, with documented protocols, calibrated equipment, and traceable records, are widely accepted as supporting evidence in the preclinical sections of medical device and pharmaceutical regulatory submissions.